Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes

Diabetologia

Volumn 54, Issue 3, 2011, Pages 487-495

  Gerstein, H C ^a   Mohan, V ^b   Avezum, A ^c   Bergenstal, R M ^d   Chiasson, J L ^e   Garrido, M ^f   MacKinnon, I ^g   Rao, P V ^h   Zinman, B ⁱ   Jung, H ^a   Joldersma, L ^a   Bosch, J ^a   Yusuf, S ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Dr Mohan's Diabetes Specialities Centre   (India)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d INTERNATIONAL DIABETES CENTER   (United States)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Clinica Privada   (Argentina)

^g Instituto de Investigaciones Clinicas   (Argentina)

^h NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Diabetes prevention; Legacy effect; Ramipril; Randomised; Rosiglitazone

Indexed keywords

GLUCOSE; PLACEBO; RAMIPRIL; ROSIGLITAZONE;

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; RAMIPRIL; THIAZOLIDINEDIONES;

EID: 79953745285     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1985-4     Document Type: Article

References (17)

1. International Diabetes Federation (2009) IDF diabetes atlas, 4th edn. IDF, Brussels
2. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403 (Pubitemid 34437694)
3. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289-297 (Pubitemid 43185397)
4. Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350 (Pubitemid 32378388)
5. Kosaka K, Noda M, Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67:152-162 (Pubitemid 40093025)
6. Pan XR, Li GW, Hu YW et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544
7. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077 (Pubitemid 34680970)
8. Gerstein HC, Yusuf S, Bosch J et al (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096-1105
9. Hanley AJ, Zinman B, Sheridan P, Yusuf S, Gerstein HC (2010) Effect of rosiglitazone and ramipril on β-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial. Diabetes Care 33:608-613
10. DREAM Trial Investigators (2004) Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial. Diabetologia 47:1519-1527
11. Bosch J, Yusuf S, Gerstein HC et al (2006) Effect of ramipril on the incidence of diabetes. N Engl J Med 355:1551-1562 (Pubitemid 44550032)
12. Knowler WC, Hamman RF, Edelstein SL et al (2005) Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 54:1150-1156 (Pubitemid 40446330)
13. Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51:2796-2803 (Pubitemid 34970933)
14. Lindstrom J, Ilanne-Parikka P, Peltonen M et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673-1679 (Pubitemid 46048554)
15. Knowler WC, Fowler SE, Hamman RF et al (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374:1677-1686
16. Li G, Zhang P, Wang J et al (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371:1783-1789 (Pubitemid 351697954)
17. Kahn SE, Haffner SM, Heise MA et al (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427-2443 (Pubitemid 44903747)